AUTHOR=Zhang Dong , Zhao Zhiyong , Gao Guofeng , Xu Han , Wang Hao , Liu Shuai , Yin Dong , Feng Lei , Zhu Chenggang , Wang Yang , Zhao Yanyan , Yang Yuejin , Gao Runlin , Xu Bo , Dou Kefei 

TITLE=Jailed Balloon Technique Is Superior to Jailed Wire Technique in Reducing the Rate of Side Branch Occlusion: Subgroup Analysis of the Conventional Versus Intentional StraTegy in Patients With High Risk PrEdiction of Side Branch OccLusion in Coronary Bifurcation InterVEntion Trial

JOURNAL=Frontiers in Cardiovascular Medicine

VOLUME=9

YEAR=2022

URL=https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2022.814873

DOI=10.3389/fcvm.2022.814873

ISSN=2297-055X

ABSTRACT=<sec><title>Objective</title><p>Jailed balloon technique (JBT) is an active side branch (SB) protection strategy and is considered to be superior to the jailed wire technique (JWT) in reducing SB occlusion. However, no randomized trials have proved that. We aim to investigate whether JBT could decrease the SB occlusion rate.</p></sec><sec><title>Methods</title><p>Conventional versus Intentional straTegy in patients with high Risk prEdiction of Side branch OccLusion in coronary bifurcation interVEntion (CIT-RESOLVE) (NCT02644434, registered on December 31, 2015) (<ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov" xmlns:xlink="http://www.w3.org/1999/xlink">https://clinicaltrials.gov</ext-link>) is a randomized trial that assessed the effects of different strategies on SB occlusion rate in patients with a high risk of SB occlusion. The present subgroup analysis enrolled bifurcation lesions (2 mm ≤ reference vessel diameter of SB &lt; 2.5 mm) with Visual estimation for Risk prEdiction of Side branch OccLusion in coronary bifurcation intervention (V-RESOLVE) score ≥ 12 points. The primary endpoint is SB occlusion. One-year clinical events were compared.</p></sec><sec><title>Results</title><p>A total of 284 subjects at 16 sites were randomly assigned to the JBT group (<italic>n</italic> = 143) or the JWT group (<italic>n</italic> = 141). The rate of SB occlusion (9.1 vs. 19.9%, <italic>p</italic> = 0.02) and periprocedural myocardial infarction (defined by WHO, 7 vs. 14.9%, <italic>p</italic> = 0.03) is significantly lower in the JBT group than in the JWT group. The JBT and JWT groups showed no significant differences in cardiac death (0.7 vs. 0.7%, <italic>p</italic> = 1), myocardial infarction (MI, 6.3 vs. 7.1%, <italic>p</italic> = 0.79), target lesion revascularization (TLR, 1.4 vs. 2.1%, <italic>p</italic> = 0.68), and major cardiac adverse events (MACE, a composite of all-cause death, MI, or TLR, 8.4 vs. 10.6%, <italic>p</italic> = 0.52) during a 1-year follow-up.</p></sec><sec><title>Conclusion</title><p>In patients with a high risk of SB occlusion (V-RESOLVE score ≥ 12 points), JBT is superior to JWT in reducing SB occlusion. However, no significant differences were detected in 1-year MACE.</p></sec>